Back to top
more

Innospec (IOSP)

(Real Time Quote from BATS)

$79.31 USD

79.31
6,525

-0.04 (-0.05%)

Updated Aug 5, 2025 10:26 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (230 out of 246)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Anindya Barman headshot

Chemical - Diversified Stock Outlook: Good Run to Continue

by Anindya Barman

Notwithstanding some headwinds, the chemical diversified industry's upturn is expected to continue in the near future as the fundamental driving factors remain in place.

    Zacks Equity Research

    Innospec (IOSP) Up 15% in 3 Months: What's Behind the Rally?

    by Zacks Equity Research

    Solid Q1 results and upbeat prospects have contributed to a rally in Innospec's (IOSP) shares.

      Zacks Equity Research

      Why Innospec (IOSP) Stock Might be a Great Pick

      by Zacks Equity Research

      Innospec (IOSP) is seeing solid earnings estimate revision activity and is a great company from a Zacks Industry Rank perspective.

        Zacks Equity Research

        5 Reasons to Add Innospec (IOSP) to Your Portfolio Now

        by Zacks Equity Research

        Strong fundamentals and upbeat prospects make Innospec (IOSP) an attractive choice for investment.

          Zacks Equity Research

          Innospec Initiates Site Construction for DRA Manufacturing

          by Zacks Equity Research

          Innospec (IOSP) initiates construction of a new site for manufacturing of DRAs in Texas which offers low cost and improved productivity to its customers.

            Zacks Equity Research

            Innospec (IOSP) Q1 Earnings Top Estimates, Sales Up Y/Y

            by Zacks Equity Research

            Strong performance across most segments drove Innospec's (IOSP) Q1 results.

              Zacks Equity Research

              What Could Dampen Chemical Industry Momentum?

              by Zacks Equity Research

              There are a few reasons to be mindful about the chemical industry in the near term.

                Zacks Equity Research

                New Strong Sell Stocks for March 2nd

                by Zacks Equity Research

                Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                  Zacks Equity Research

                  Innospec (IOSP) Q4 Earnings Top Estimates, Sales Up Y/Y

                  by Zacks Equity Research

                  Innospec's (IOSP) adjusted earnings surpassed expectations in Q4 while gains across all segments drove its top line in the quarter.

                    Zacks Equity Research

                    Here's Why Innospec (IOSP) Should Be in Your Portfolio Now

                    by Zacks Equity Research

                    Based on its compelling prospects, we believe Innospec (IOSP) has plenty of upside potential.

                      Zacks Equity Research

                      Innospec (IOSP) Up 27% in 3 Months: What's Driving It?

                      by Zacks Equity Research

                      Solid Q3 results have contributed to a rally in Innospec's (IOSP) shares.

                        Zacks Equity Research

                        Innospec (IOSP) Q3 Earnings Top Estimates, Sales Rise Y/Y

                        by Zacks Equity Research

                        Strong sales gains across all core businesses drove Innospec's (IOSP) Q3 results.

                          Zacks Equity Research

                          5 Chemical Stocks to Enrich Your Portfolio Before Q3 Earnings

                          by Zacks Equity Research

                          Chemical companies are expected to continue the earnings momentum in Q3 as the fundamental driving factors remain firmly in place.

                            Zacks Equity Research

                            Should Value Investors Consider Innospec (IOSP) Stock Now?

                            by Zacks Equity Research

                            Is Innospec Inc. (IOSP) a great pick from the value investor's perspective right now? Read on to know more.

                              Zacks Equity Research

                              Here's Why Innospec (IOSP) Should Be in Your Portfolio Now

                              by Zacks Equity Research

                              Upbeat outlook and compelling growth prospects make Innospec (IOSP) an attractive choice for investment.

                                Zacks Equity Research

                                Innospec (IOSP) Sets Up Fully-Owned Enterprise in China

                                by Zacks Equity Research

                                Innospec (IOSP) announces the completion of its fully-owned enterprise's registration in China. The move is likely to extend the company's footprint in global markets.

                                  Zacks Equity Research

                                  Innospec (IOSP) Ecoclean Cleared as Top Tier Diesel Additive

                                  by Zacks Equity Research

                                  Innospec's (IOSP) Ecoclean 4200 detergent receives approval as a Top Tier diesel additive.

                                    Zacks Equity Research

                                    Huntsman Proceeds with Clariant Deal, To Address FTC Concerns

                                    by Zacks Equity Research

                                    Huntsman (HUN) moves forward with Clariant Deal and is confident of addressing all regulatory concerns well in-advance.

                                      Zacks Equity Research

                                      Innospec (IOSP) Q2 Earnings Top Estimates, Sales Up Y/Y

                                      by Zacks Equity Research

                                      Innospec (IOSP) topped earnings expectations in Q2 on strong gains across Performance Chemicals and Oilfield Services units.

                                        Zacks Equity Research

                                        Huntsman Declares Venator IPO Completion, Plans to Cut Debt

                                        by Zacks Equity Research

                                        Huntsman Corporation (HUN) announced the completion of Venator IPO and plans to use the net proceeds to repay existing debt.

                                          Zacks Equity Research

                                          Huntsman Declares Completion of $375M Senior Notes Offering

                                          by Zacks Equity Research

                                          Huntsman (HUN) and Venator have completed the private offering of $375 million senior notes, marking a key step in the separation of the Pigments & Additives unit.

                                            Zacks Equity Research

                                            6 Reasons that Make Albemarle (ALB) a Solid Choice Now

                                            by Zacks Equity Research

                                            Strong fundamentals and compelling growth prospects make Albemarle an attractive choice for investment.

                                              Zacks Equity Research

                                              Eastman Chemical vs Albemarle: Which Stock Is a Better Pick?

                                              by Zacks Equity Research

                                              Which Zacks Rank #2 stock is better placed in terms of fundamentals - Eastman Chemical (EMN) or Albemarle (ALB)?

                                                Zacks Equity Research

                                                Allegheny (ATI), GE Aviation Form Meltless Titanium JV

                                                by Zacks Equity Research

                                                Allegheny (ATI) has formed a joint venture with GE Aviation for developing a new meltless titanium alloy powder manufacturing technology.

                                                  Zacks Equity Research

                                                  PolyOne to Sell DSS Unit to Arsenal Capital for $115 Million

                                                  by Zacks Equity Research

                                                  PolyOne (POL) is selling its Designed Structures and Solutions (DSS) business to Arsenal Capital Partners for $115 million.